Application 206071
- Type
- ANDA
- Sponsor
- NAVINTA LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | METHOCARBAMOL | METHOCARBAMOL | SOLUTION;IM-IV | 1GM/10ML (100MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206071-001 | METHOCARBAMOL | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION / IM-IV | 2017-11-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A206071-001 | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION / IM-IV | AP | 2017-11-24 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A206071-001 | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION / IM-IV | AP | 2017-11-24 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A206071-001 | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION / IM-IV | AP | 2017-11-24 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A206071-001 | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION / IM-IV | AP | 2017-11-24 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A206071-001 | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION / IM-IV | 2017-11-24 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206071-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-10-29 15:01 UTC | 2024-10 | A206071-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206071-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206071-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A206071-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A206071-001 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A206071-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A206071-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A206071-001 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A206071-001 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A206071-001 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A206071-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A206071-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A206071-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A206071-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A206071-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A206071-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A206071-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A206071-001 | AP | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A206071-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A206071-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A206071-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A206071-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A206071-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A206071-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A206071-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A206071-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A206071-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A206071-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A206071-001 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A206071-001 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A206071-001 | AP | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | Marlex Pharmaceuticals, Inc. | d2e38ac9-1cf3-14ca-e053-2a95a90a8522 | 2026-11-06 | Warnings, Adverse reactions | METHOCARBAMOL |
| Methocarbamol | METHOCARBAMOL | Doc Rx | 5e55526f-bb34-4b67-85ea-b2765e8066bb | 2026-11-05 | Warnings, Adverse reactions | Methocarbamol METHOCARBAMOL |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 72f36d28-15d2-30f6-e053-2a91aa0ad1ce | 2026-11-05 | Warnings, Adverse reactions | Methocarbamol |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6500c6eb-fa1e-46a5-839f-13047e107e97 | 2026-11-04 | Warnings, Adverse reactions | METHOCARBAMOL |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6ca768bf-5095-4148-82d2-a0c2dec16d87 | 2026-11-03 | Warnings, Adverse reactions | METHOCARBAMOL |
| Methocarbamol | METHOCARBAMOL TABLETS | American Health Packaging | 1b5afc6c-e09c-41bd-8b7e-d12051b33a4b | 2026-10-29 | Warnings, Adverse reactions | Methocarbamol |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | d8e3f8dc-9751-419b-8601-d85c43415c82 | 2026-10-16 | Warnings, Adverse reactions | Methocarbamol METHOCARBAMOL |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | d217bd1d-0b6e-4a4c-a47b-de73b94e8b13 | 2026-10-16 | Warnings, Adverse reactions | Methocarbamol METHOCARBAMOL |
| Methocarbamol | METHOCARBAMOL | REGIMED MEDICAL | d4433a71-5cf9-4a32-8902-1c522f1a9acd | 2026-10-13 | Warnings, Adverse reactions | Methocarbamol METHOCARBAMOL |
| Methocarbamol | METHOCARBAMOL TABLETS | Granules India Ltd | 42c0a177-7d62-4bcf-9fce-7dd484cda4d5 | 2026-10-07 | Warnings, Adverse reactions | Methocarbamol |
| METHOCARBAMOL | METHOCARBAMOL | Henry Schein, Inc | d48d76af-b55a-4908-95ff-e7de615c0513 | 2026-10-05 | Warnings, Adverse reactions | METHOCARBAMOL METHOCARBAMOL |
| Methocarbamol | METHOCARBAMOL | ASCLEMED USA INC. | 077fa923-bee0-4b34-a52d-6f870bcb4828 | 2026-09-29 | Warnings, Adverse reactions | Methocarbamol METHOCARBAMOL |
| Methocarbamol | METHOCARBAMOL TABLETS | PD-Rx Pharmaceuticals, Inc. | 7dafab15-db4c-4425-b1a2-e56433ecccf6 | 2026-09-23 | Warnings, Adverse reactions | Methocarbamol |
| Methocarbamol | METHOCARBAMOL TABLETS | PD-Rx Pharmaceuticals, Inc. | d0acdf52-e1a9-4489-91e1-ef434d311613 | 2026-09-23 | Warnings, Adverse reactions | Methocarbamol |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | e5fe4627-11cb-4ebd-8eb0-9be807446fdf | 2026-09-23 | Warnings, Adverse reactions | Methocarbamol |
| Methocarbamol | METHOCARBAMOL | St. Mary's Medical Park Pharmacy | 5bc70fe6-67a6-795b-e063-6394a90a1193 | 2026-09-17 | Warnings, Adverse reactions | Methocarbamol METHOCARBAMOL |
| Methocarbamol | METHOCARBAMOL | Aphena Pharma Solutions - Tennessee, LLC | 5b9b48e2-4ff4-3ceb-e063-6394a90a0499 | 2026-09-16 | Warnings, Adverse reactions | Methocarbamol METHOCARBAMOL |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 3e4c88fe-bc3d-463f-973c-e52062e4d4ba | 2026-09-14 | Warnings, Adverse reactions | Methocarbamol |
| Methocarbamol | METHOCARBAMOL | REMEDYREPACK INC. | 87ff444e-d502-428c-8be7-89d36c0cf709 | 2026-09-11 | Warnings, Adverse reactions | Methocarbamol METHOCARBAMOL |
| Methocarbamol | METHOCARBAMOL TABLETS | Coupler LLC | 5a585c87-6361-420d-e063-6294a90a1838 | 2026-08-31 | Warnings, Adverse reactions | Methocarbamol |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
Documents#
| Document | Submission type | Date |
|---|---|---|
| 50512 | ORIG | 2017-11-27 |